Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-13 Purchase |
2024-06-14 4:05 pm |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
22,617,909 | $2.42 | $54,735,340 | 22,617,909 (Indirect) |
View |
| 2023-06-28 Purchase |
2023-06-28 4:01 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
130,000 | $29.51 | $3,836,768 | 3,758,980 (Indirect Direct) |
View |
| 2023-06-12 Purchase |
2023-06-13 4:01 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
90,000 | $32.89 | $2,959,848 | 3,628,980 (Indirect Direct) |
View |
| 2023-05-24 Purchase |
2023-05-24 6:45 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
150,000 | $32.25 | $4,837,440 | 3,538,980 (Indirect Direct) |
View |
| 2023-05-16 Purchase |
2023-05-17 6:41 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
230,000 | $33.38 | $7,676,824 | 3,388,980 (Indirect Direct) |
View |
| 2022-01-31 Purchase |
2022-02-01 4:17 pm |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner |
22,666,667 | $1.5 | $34,000,001 | 31,930,464 (Indirect Direct) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:55 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
20,000 | $28 | $560,000 | 7,885,433 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-04 Conversion |
2025-02-06 5:02 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
1,065,070 | $0 | 199,365,296 (Indirect) |
View |
| 2025-02-04 Other |
2025-02-06 5:02 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
532,535 | $0 | 199,365,296 (Indirect) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:33 pm |
N/A 2034-05-30 |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Director |
62,558 | $0 | 62,558 (Direct) |
View |
| 2024-02-05 Conversion |
2024-02-06 4:05 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
1,497,904 | $0 | 178,028,874 (Indirect) |
View |
| 2024-02-05 Other |
2024-02-06 4:05 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
748,952 | $0 | 178,028,874 (Indirect) |
View |
| 2022-12-30 Gift |
2023-11-16 5:50 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
292,190 | $0 | 4,051,170 (Indirect) |
View |
| 2023-11-16 Other |
2023-11-16 5:50 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
383,000 | $0 | 4,051,170 (Direct) |
View |
| 2023-10-30 Conversion |
2023-11-01 5:27 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
10,578,110 | $0 | 184,066,881 (Indirect) |
View |
| 2023-10-30 Other |
2023-11-01 5:27 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
5,289,055 | $0 | 184,066,881 (Indirect) |
View |
| 2023-06-29 Option Award |
2023-07-03 09:16 am |
N/A 2033-06-29 |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Director 10% Owner |
48,128 | $0 | 48,128 (Direct) |
View |
| 2023-05-12 Gift |
2023-05-15 9:34 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
20,538 | $0 | 1,700,189 (Indirect) |
View |
| 2022-08-12 Ownership |
2023-02-10 7:48 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
150,640 | $0 | 5,709,377 (Indirect) |
View |
Ownership |
2023-02-10 7:48 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
0 | $0 | 5,709,377 (Indirect) |
View |
| 2022-08-12 Equity Swap |
2022-08-16 6:55 pm |
N/A N/A |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner |
31,933,334 | $0 | 0 (Indirect) |
View |
| 2022-07-11 Option Award |
2022-07-13 9:30 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
199,855,936 | $0 | 199,855,936 (Indirect) |
View |
Ownership |
2022-07-13 9:06 pm |
N/A N/A |
PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner |
0 | $0 | 0 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 6:01 pm |
2023-05-17 2032-05-16 |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner |
41,006 | $0.56 | 31,980,464 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 6:01 pm |
2023-05-17 N/A |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner |
8,994 | $0 | 31,980,464 (Direct) |
View |
| 2020-06-16 Conversion |
2022-04-15 6:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
1,198,821 | $0 | 36,641,176 (Indirect) |
View |
| 2021-03-23 Other |
2022-04-15 6:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
917,322 | $0 | 36,641,176 (Indirect) |
View |
| 2020-06-15 Option Award(A) |
2022-04-15 6:49 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
1,719,074 | $0 | 1,719,074 (Indirect) |
View |
Ownership(A) |
2022-04-15 6:45 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board |
0 | $0 | 12,106,264 (Indirect) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:14 pm |
2022-06-11 2031-06-11 |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner |
40,559 | $8.53 | 9,263,797 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:14 pm |
2022-06-11 N/A |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner |
8,060 | $0 | 9,263,797 (Direct) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:03 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board |
2,557,500 | $0 | 7,406,417 (Indirect) |
View |
| 2020-06-18 Conversion |
2020-06-22 9:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
265,991 | $0 | 7,885,433 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
7,765,047 | $0 | 7,885,433 (Indirect) |
View |
Ownership |
2020-06-15 9:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board |
0 | $0 | 62,552,304 (Indirect) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:23 pm |
2021-05-29 2029-05-29 |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner |
14,103 | $0 | 9,215,178 (Direct) |
View |